These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 27753767)

  • 1. Five-year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-based Accompaniment Program in Rural Rwanda.
    Cyamatare Rwabukwisi F; Hedt-Gauthier BL; Ribakare M; Mukamana J; Gatesi Y; Stulac S; Drobac P; Amoroso CL; Gupta N
    Pediatr Infect Dis J; 2016 Nov; 35(11):1222-1224. PubMed ID: 27753767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Based Accompaniment and the Impact of Distance for HIV Patients Newly Initiated on Antiretroviral Therapy: Early Outcomes and Clinic Visit Adherence in Rural Rwanda.
    Munyaneza F; Ntaganira J; Nyirazinyoye L; Birru E; Nisingizwe MP; Gupta N; Amoroso CL; Neza G; Hirschhorn LR; Hedt-Gauthier BL
    AIDS Behav; 2018 Jan; 22(1):77-85. PubMed ID: 28025738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda.
    Gupta N; Munyaburanga C; Mutagoma M; Niyigena JW; Kayigamba F; Franke MF; Hedt-Gauthier B
    AIDS Behav; 2016 May; 20(5):1009-16. PubMed ID: 26346334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda.
    Nsanzimana S; McArdle F; Remera E; Mulindabigwi A; Ribakare M; Ndimubanzi P; Kayirangwa E; Baribwira C; Riedel DJ; Ntaganira J
    Pediatr Infect Dis J; 2019 Feb; 38(2):149-151. PubMed ID: 29794653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study.
    Thomson DR; Rich ML; Kaigamba F; Socci AR; Hakizamungu M; Bagiruwigize E; Binagwaho A; Franke MF
    AIDS Behav; 2014 Feb; 18(2):368-80. PubMed ID: 23443977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.
    Kayigamba FR; Franke MF; Bakker MI; Rodriguez CA; Bagiruwigize E; Wit FW; Rich ML; Schim van der Loeff MF
    PLoS One; 2016; 11(7):e0159446. PubMed ID: 27438000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to care.
    Matthews PE; Le T; Delmar J; Okulicz JF
    Int J STD AIDS; 2015 Nov; 26(13):951-9. PubMed ID: 25505041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load detection and management on first line ART in rural Rwanda.
    Ndagijimana Ntwali JD; Decroo T; Ribakare M; Kiromera A; Mugwaneza P; Nsanzimana S; Lynen L
    BMC Infect Dis; 2019 Jan; 19(1):8. PubMed ID: 30606128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.
    van Griensven J; De Naeyer L; Uwera J; Asiimwe A; Gazille C; Reid T
    BMC Pediatr; 2008 Oct; 8():39. PubMed ID: 18831747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
    Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community Based Antiretroviral Treatment in Rural Zimbabwe.
    Chimukangara B; Manasa J; Mitchell R; Nyabadza G; Katzenstein D; Masimirembwa C
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1185-1191. PubMed ID: 28899102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
    Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
    BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
    Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staged introduction of antiretroviral therapy into a family with multiple HIV-infected members.
    Fielder JF; Kwatampora L
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):68-72. PubMed ID: 19171913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality along the continuum of HIV care in Rwanda: a model-based analysis.
    Bendavid E; Stauffer D; Remera E; Nsanzimana S; Kanters S; Mills EJ
    BMC Infect Dis; 2016 Dec; 16(1):728. PubMed ID: 27905895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.